We have no Upcoming Events scheduled
Sign up to receive updates on VYJUVEK and upcoming events here: https://www.vyjuvek.com/connect/
|INDICATION AND USAGE|
VYJUVEK is a topical gel used to treat wounds in patients 6 months and older with dystrophic epidermolysis bullosa (DEB).
IMPORTANT SAFETY INFORMATION
VYJUVEK gel must be applied by a healthcare provider.
After treatment, patients and caregivers should be careful not to touch treated wounds and dressings for 24 hours. If accidentally exposed to the VYJUVEK gel, clean the affected area.
Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent, and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.
Patients should avoid touching or scratching wound sites or wound dressings.
The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny
nose. These are not all the possible side effects with VYJUVEK.
Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at
1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.
Please see Important Safety Information throughout and click here for full Prescribing Information.
VYJUVEK™ and its associated logo are trademark owned by Krystal Biotech, Inc.|
© Krystal Biotech, Inc. 2023 All Rights Reserved.
VYJ-2300055 v1.0 July 2023